Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: AMERISOURCEBERGEN DRUG CORP
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-11-04 to 2024-11-05
Current total value of award: $5701.86
Description: 4566321034!QUILLIVANT XR ORAL SUSP 60ML 5MG/ML